Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapies Post author: Post published:March 18, 2024 Post category:uncategorized Immunome signs deal to use Arrayjet platform in its in-house screening operations. You Might Also Like Aptamer and Neuro-Bio enter the second phase of Alzheimer’s test development February 22, 2024 Researchers identify cause and potential therapeutic approach for diabetic kidney disease October 10, 2024 Study links pneumonia transmission in seniors to contact with young children April 3, 2024
Researchers identify cause and potential therapeutic approach for diabetic kidney disease October 10, 2024